Previous Close | 226.38 |
Open | 226.07 |
Bid | 226.93 x 800 |
Ask | 227.10 x 800 |
Day's Range | 224.16 - 228.43 |
52 Week Range | 180.93 - 348.67 |
Volume | |
Avg. Volume | 353,865 |
Market Cap | 8.805B |
Beta (5Y Monthly) | 0.52 |
PE Ratio (TTM) | 98.48 |
EPS (TTM) | 2.31 |
Earnings Date | Apr 30, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 279.15 |
Subscribe to Yahoo Finance Plus to view Fair Value for PEN
It is hard to get excited after looking at Penumbra's (NYSE:PEN) recent performance, when its stock has declined 13...
Penumbra (PEN) expects to materially increase both revenues and profitability in the company's international business in the next three years and beyond.
Penumbra's (PEN) Q4 revenues register year-over-year growth driven by robust U.S. thrombectomy sales.